Independent Portfolio Consultants’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$13K Sell
165
-430
-72% -$32.1K 0.01% 668
2017
Q1
$44K Sell
595
-325
-35% -$23.6K 0.02% 580
2016
Q4
$62K Sell
920
-10
-1% -$645 0.02% 515
2016
Q3
$62K Sell
930
-360
-28% -$22.9K 0.02% 509
2016
Q2
$77K Sell
1,290
-4,565
-78% -$247K 0.02% 489
2016
Q1
$285K Buy
5,855
+505
+9% +$22.9K 0.08% 293
2015
Q4
$289K Buy
5,350
+630
+13% +$32.1K 0.09% 285
2015
Q3
$228K Sell
4,720
-110
-2% -$5.68K 0.05% 329
2015
Q2
$229K Buy
4,830
+640
+15% +$29.9K 0.05% 341
2015
Q1
$193K Sell
4,190
-10
-0.2% -$465 0.04% 366
2014
Q4
$198K Sell
4,200
-8,520
-67% -$355K 0.04% 377
2014
Q3
$444K Buy
12,720
+385
+3% +$13.7K 0.12% 255
2014
Q2
$439K Buy
12,335
+950
+8% +$32.5K 0.12% 274
2014
Q1
$437K Buy
11,385
+325
+3% +$11.9K 0.14% 278
2013
Q4
$358K Buy
+11,060
New +$332K 0.13% 333

Other funds holding NUVA

Independent Portfolio Consultants's NUVA Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its NuVasive, Inc. (NUVA) stake by 72% in Q2 2017, selling an estimated $32.1K and leaving 165 shares worth $13K. The position accounts for 0.01% of the portfolio, ranked #668.

Independent Portfolio Consultants first reported a position in NUVA in Q4 2013 and has held it in 15 quarters since. The position peaked at $444K in Q3 2014. 298 funds tracked by Wall St. Rank hold NUVA as of Q2 2017.

  • Independent Portfolio Consultants held 165 shares of NuVasive, Inc. worth $13K as of Q2 2017.
  • Independent Portfolio Consultants sold 430 NuVasive, Inc. shares in Q2 2017, an estimated $32.1K.
  • NuVasive, Inc. made up 0.01% of Independent Portfolio Consultants's portfolio in Q2 2017, its #668 holding.
  • Independent Portfolio Consultants first reported a position in NuVasive, Inc. in Q4 2013 and has held it in 15 quarters since.
  • Independent Portfolio Consultants's NuVasive, Inc. position peaked at $444K in Q3 2014.
  • 298 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.